HOWLWerewolf Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Werewolf Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOWL본 종목 | $47M#8 | — | 2.9x#7 | — | — | 13.7%#7 | — | -373.3%#9 | -229.9%#3 | — | -32.2%#2 | — |
| SER | $56M#1 | — | — | 427.9x#11 | 132.1%#4 | -72.2%#13 | -18478.5%#11 | — | — | 5#2 | -57.1%#5 | — |
| HYPD | $54M#2 | — | 0.5x#1 | 66.3x#9 | 1318.8%#1 | 9.0%#8 | -5743.5%#8 | -44.5%#3 | -46.8%#1 | — | -71.7%#7 | — |
| CLNN | $54M#3 | — | — | 269.2x#10 | -41.5%#8 | 33.6%#5 | -11541.5%#9 | — | — | — | -33.9%#3 | — |
| XLO | $52M#4 | — | 0.7x#3 | 1.2x#2 | 589.9%#2 | 39.8%#4 | -95.9%#3 | -48.5%#5 | — | — | — | — |
| VBIO | $50M#5 | — | 11.8x#10 | 64.0x#7 | -33.7%#7 | -57.0%#12 | -1012.6%#5 | -209.1%#8 | — | — | — | — |
| ELTX | $49M#6 | — | 6.2x#8 | 21.2x#5 | -91.9%#9 | 23.8%#6 | -1639.0%#7 | -498.6%#10 | — | — | -83.9%#8 | — |
| PDSB | $48M#7 | — | — | — | — | 8.3%#9 | — | — | -541.6%#5 | — | -26.1%#1 | — |
| ANVS | $46M#9 | — | — | — | — | -17.3%#10 | — | — | — | — | -53.6%#4 | — |
| SCYX | $44M#10 | 15.9x#1 | 0.7x#2 | 2.2x#3 | 449.9%#3 | 59.6%#2 | -78.0%#2 | -12.9%#2 | — | 7#1 | — | — |
| KAPA | $42M#11 | — | 10.1x#9 | — | — | -109.3%#14 | — | -130.0%#7 | — | — | — | — |
| MCRB | $41M#12 | — | 1.2x#4 | 52.0x#6 | — | 4088.2%#1 | -11910.1%#10 | 16.5%#1 | -72.9%#2 | — | — | — |
| VERU | $41M#13 | — | 1.4x#5 | 2.4x#4 | 3.6%#5 | 39.9%#3 | -146.6%#4 | -80.1%#6 | -399.3%#4 | — | — | 0.0%#1 |
| KPTI | $41M#14 | — | — | 0.3x#1 | 0.6%#6 | -156.5%#15 | -62.1%#1 | — | — | — | -70.7%#6 | — |
| ELAB | $39M#15 | — | 2.3x#6 | 65.6x#8 | — | -24.0%#11 | -1304.4%#6 | -46.3%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice